3362. Genetic Defect in Submucosal Gland-Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk.
作者: Katherine S Garman.;Biswa P D Purkayastha.;Joyce A Hogue.;Ryan Fecteau.; .;Kishore Guda.;Amitabh Chak.
来源: Gastroenterology. 2023年165卷6期1561-1564.e3页 3365. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
作者: Laurent Peyrin-Biroulet.;Jessica R Allegretti.;David T Rubin.;Brian Bressler.;Matthew Germinaro.;Kuan-Hsiang Gary Huang.;Nicole Shipitofsky.;Hongyan Zhang.;Rebbecca Wilson.;Chenglong Han.;Brian G Feagan.;William J Sandborn.;Julian Panés.;Tadakazu Hisamatsu.;Gary R Lichtenstein.;Bruce E Sands.;Axel Dignass.; .
来源: Gastroenterology. 2023年165卷6期1443-1457页
The QUASAR Phase 2b Induction Study evaluated the efficacy and safety of guselkumab, an interleukin-23p19 subunit antagonist, in patients with moderately to severely active ulcerative colitis (UC) with prior inadequate response and/or intolerance to corticosteroids, immunosuppressants, and/or advanced therapy.
3366. Risk of Cancer and Mortality in Peutz-Jeghers Syndrome and Juvenile Polyposis Syndrome-A Nationwide Cohort Study With Matched Controls.
作者: Anne Marie Jelsig.;Laus Wullum.;Tine Plato Kuhlmann.;Lilian Bomme Ousager.;Johan Burisch.;John Gásdal Karstensen.
来源: Gastroenterology. 2023年165卷6期1565-1567.e2页 3369. Multistate Model of the Natural History of Inflammatory Pancreatic Diseases: A Nationwide Population-based Cohort Study.
作者: Mathias Ellgaard Cook.;Niels Henrik Bruun.;Line Davidsen.;Asbjørn Mohr Drewes.;Søren Schou Olesen.
来源: Gastroenterology. 2023年165卷6期1547-1557.e4页
Understanding the nature of inflammatory pancreatic diseases is essential for planning health care system requirements and interventions. The aim of this study was to quantify the trajectories of inflammatory pancreatic diseases and their association with pancreatic cancer in a population-based setting.
3371. The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia.
作者: Amir M Khoshiwal.;Nicola F Frei.;Roos E Pouw.; .;Christian Smolko.;Meenakshi Arora.;Jennifer J Siegel.;Lucas C Duits.;Rebecca J Critchley-Thorne.;Jacques J G H M Bergman.
来源: Gastroenterology. 2023年165卷5期1168-1179.e6页
Low-grade dysplasia (LGD) is associated with an increased risk of progression in Barrett's esophagus (BE); however, the diagnosis of LGD is limited by substantial interobserver variability. Multiple studies have shown that an objective tissue systems pathology test (TissueCypher Barrett's Esophagus Test, TSP-9), can effectively predict neoplastic progression in patients with BE. This study aimed to compare the risk stratification performance of the TSP-9 test vs benchmarks of generalist and expert pathology.
3372. Automated Artificial Intelligence Model Trained on a Large Data Set Can Detect Pancreas Cancer on Diagnostic Computed Tomography Scans As Well As Visually Occult Preinvasive Cancer on Prediagnostic Computed Tomography Scans.
作者: Panagiotis Korfiatis.;Garima Suman.;Nandakumar G Patnam.;Kamaxi H Trivedi.;Aashna Karbhari.;Sovanlal Mukherjee.;Cole Cook.;Jason R Klug.;Anurima Patra.;Hala Khasawneh.;Naveen Rajamohan.;Joel G Fletcher.;Mark J Truty.;Shounak Majumder.;Candice W Bolan.;Kumar Sandrasegaran.;Suresh T Chari.;Ajit H Goenka.
来源: Gastroenterology. 2023年165卷6期1533-1546.e4页
The aims of our case-control study were (1) to develop an automated 3-dimensional (3D) Convolutional Neural Network (CNN) for detection of pancreatic ductal adenocarcinoma (PDA) on diagnostic computed tomography scans (CTs), (2) evaluate its generalizability on multi-institutional public data sets, (3) its utility as a potential screening tool using a simulated cohort with high pretest probability, and (4) its ability to detect visually occult preinvasive cancer on prediagnostic CTs.
3373. Cell-in-Cell-Mediated Entosis Reveals a Progressive Mechanism in Pancreatic Cancer.
作者: Jianlu Song.;Ruiyuan Xu.;Hui Zhang.;Xuemin Xue.;Rexiati Ruze.;Yuan Chen.;Xinpeng Yin.;Chengcheng Wang.;Yupei Zhao.
来源: Gastroenterology. 2023年165卷6期1505-1521.e20页
Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy with high intratumoral heterogeneity. There is a lack of effective therapeutics for PDAC. Entosis, a form of nonapoptotic regulated cell death mediated by cell-in-cell structures (CICs), has been reported in multiple cancers. However, the role of entosis in PDAC progression remains unclear.
3377. Association between tea consumption and colorectal cancer: a systematic review and meta-analysis of a population-based study.
作者: Yu Huang.;Qiang Chen.;Yating Liu.;Ruoxi Tian.;Xu Yin.;Yaoguang Hao.;Yang Yang.;Jian Yang.;Zongxuan Li.;Suyang Yu.;Hongyan Li.;Guiying Wang.
来源: BMC Gastroenterol. 2023年23卷1期294页
A meta-analysis study was performed to systematically assess the association between tea consumption and CRC risk.
3378. Milligan-Morgan hemorrhoidectomy combined with non-doppler hemorrhoidal artery ligation for the treatment of grade III/IV hemorrhoids: a single centre retrospective study.
Milligan-Morgan hemorrhoidectomy (MMH) is the most widely used surgical procedure because of its precise curative effect, but it has the disadvantages such as obvious postoperative pain and bleeding. To retrospectively evaluate the efficacy and safety of MMH combined with non-Doppler hemorrhoidal artery ligation (MMH + ND-HAL) for the treatment of grade III/IV hemorrhoids.
3379. TRIM69: a marker of metastasis and potential sensitizer to 5-Fluorouracil and PD-1 blockers in colon adenocarcinoma.
作者: Xiao-Jv Chi.;Yi-Bei Song.;Deng-He Liu.;Li-Qiang Wei.;An-Ran Zhao.;Xin An.;Zi-Zhen Feng.;Xiao-Hua Lan.;Yu-Meng Lv.;Hong-Jun Li.;Dong Lan.;Hui-Min He.
来源: BMC Gastroenterol. 2023年23卷1期292页
Several proteins in the tripartite-motif (TRIM) family are associated with the development of colorectal cancer (CRC), but research on the role of TRIM69 was lacking. The present study examined the correlation between TRIM69 expression and colon adenocarcinoma (COAD).
3380. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?
Gastric intestinal metaplasia (GIM), which denotes conversion of gastric mucosa into an intestinal phenotype, can occur in all regions of the stomach, including cardiac, fundic, and pyloric mucosa. Since the earliest description of GIM, its association with gastric cancer of the differentiated (intestinal) type has been a well-recognized concern. Many epidemiologic studies have confirmed GIM to be significantly associated with subsequent gastric cancer development. Helicobacter pylori, the principal etiologic factor for gastric cancer, plays the most important role in predisposing to GIM. Although the role of GIM in the stepwise progression model of gastric carcinogenesis (the so-called "Correa cascade") has come into question recently, we review the scientific evidence that strongly supports this long-standing model and propose a new progression model that builds on the Correa cascade. Eradication of H pylori is the most important method for preventing gastric cancer globally, but the effect of eradication on established GIM, is limited, if any. Endoscopic surveillance for GIM may, therefore, be necessary, especially when there is extensive corpus GIM. Recent advances in image-enhanced endoscopy with integrated artificial intelligence have facilitated the identification of GIM and neoplastic lesions, which will impact preventive strategies in the near future.
|